CYP 0.00% 23.5¢ cynata therapeutics limited

Going forward..., page-471

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    Fuji have pre-emptive rights over other indications. Celularity was a bluff imo, 1 year on and not a word.


    I note again, 3x phase 2 trials 2019, and none in conflict with FujiFilm. (how convenient?)

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.